Program

passwell2016 Program

  Print Full program

Sunday, May 1

Time Session/Lecture info
09:00-09:45
Sunday, May 1, 2016
 
09:00-09:30
Get-together and light refreshments
09:30-09:45
Michal Neeman, PhD, Vice-President, Weizmann Institute of Science
Liran Shlush, MD, PhD, Weizmann Institute of Science
Levia Passwell
09:45-13:00
Session I
Chair: Tsvee Lapidot, PhD (Weizmann Institute of Science, Israel) 
09:45-10:30
Karl Skorecki, MD , Rambam Health Care Campus, Israel
An evolutionary arms race delivers a rare example of a common variant ? common disease high risk association
10:30-11:00
Ravi Majeti, MD, PhD , Stem Cell Institute, Stanford School of Medicine, USA
Pre-leukemic hematopoietic stem cells in acute myeloid leukemia
11:00-11:30
Coffee Break
11:30-12:00
Liran Shlush, MD, PhD, Weizmann Institute of Science, Israel, and Visiting Physician, Rambam Health Care Center, Israel, and Princess Margaret Cancer Centre, Canada
Leukemia evolution
12:00-12:30
Ido Amit, PhD , Weizmann Institute of Science, Israel
Single cell genomic analysis of hematopoietic progenitors: Towards a refined model of hematopoiesis
12:30-13:00
John Welch, Washington University, USA
Order of mutations in AML: Implications for biology, residual disease detection, and treatment
13:00-14:30
Lunch
 
14:30-17:45
Session II
Chair: Martin Ellis, MD (Meir Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel) 
14:30-15:15
Shai Izraeli, MD , Safra Children’s Hospital, Sheba Medical Center, Israel
Leukemia as a developmental disorder
15:15-15:45
Olivier Bernard, PhD , Institut Gustave Roussy, France
The origin of lymphoproliferative disorders
15:45-16:15
Coffee Break
16:15-16:45
Ruud Delwel, PhD , Erasmus Medical Center, The Netherlands
Oncogenic enhancers and acute myeloid leukemia
16:45-17:15
Jacob Rowe, MD , Rambam Health Care Campus and Shaare Zedek Medical Center, Israel
Advances in the treatment of adult ALL
17:15-17:45
Discussion